Drugs in the making.com
Presented here are titles of current drug research and technology topics. For detailed reading of the subject, please follow link given below.
FDA rejects Rituxan for patients with earlier stages of RA.
CF patients appear to be taking wide variety of medication, data suggest.
Experimental nicotine vaccine fails to meet primary endpoint.
Studies see increased skin cancer risk in patients taking anti-TNF drugs.
FDA strengthens warning for Dexferrum.
Dr. Shruti U. Bhat
Pharmaceutical Manufacturing, Continuous Improvement and Business Transformation Consultant
New Release !
The information posted here, not limited to blogs, website, podcasts, videos, eBooks, whitepapers and other 'free' resources including downloaded items are Copyright protected, 'for review' purpose only. Not to be copied, distributed or used without prior written authorization by Dr. Shruti U. Bhat. Any instance(s) found to the contrary would be construed as copyright violation, illegal, plagiarism and/or could be subject to legal proceedings.
For additional details, refer our Terms & Conditions for site usage.
Kaizen book at # 4 on Amazon Best Sellers List!